The Trinity Health System School of Medical Laboratory Science graduated its seventh class, comprised of Aliyah Pattie and ...
The company rolled out a biology-centric version of Claude and hosted surprisingly forthright conversations about AI and ...
Humanmaxxing is the latest wellness trend focused on maximizing human potential through biohacking, longevity science and ...
A slew of start-ups and academic labs are leaning on AI agents and bots, rather than humans, to speed up their chemistry ...
AtaiBeckley to be added to the Russell 2000® Index and the broad-market Russell 3000® Index as part of 2026 reconstitutionThe Russell U.S.
Clinical trials prove the efficacy of psychedelic treatments. Dr. Itamar Cohen reveals the cold economic interest behind the ...
SETI scientists searched the interstellar object 3I/ATLAS for radio signals that could indicate extraterrestrial technology ...
The clinical evidence is real. The valuations are not. Compass Pathways: $560 million market cap, zero revenue. MindMed: up to $2 billion, zero revenue. Even Ozempic lost half its value with $49 ...
Wall Street closed higher on Thursday, with the S&P 500 and Nasdaq Composite climbing to fresh record highs as investors weighed a reported US-Iran ceasefire extension alongside another wave of upbeat ...
Growing investor interest in brain health, workplace resilience, and next-generation mental health treatmentsNEW YORK, May 27, 2026 (GLOBE NEWSWIRE) -- PRISM MarketView, the financial media platform ...
More than 21% of U.S. adults experience depression, greatly impacting their quality of life. Many people with mild‑to‑moderate depression can improve their symptoms by adjusting daily habits like ...
The first psychedelic-based treatments for depression and posttraumatic stress disorder (PTSD) could be approved as early as this fall, as a new FDA pathway accelerates review for particular drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results